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Background and study objective: Infections are major causes of acute exacerbations of 
chronic obstructive pulmonary disease (COPD) which result in signiﬁ  cant mortality and mor-
bidity. The primary aim of the study was to determine the microbiological spectrum including 
atypical agents in acute exacerbations. The secondary aim was to evaluate resistance patterns 
in the microorganisms.
Methods: The sputum culture of 75 patients admitted to our clinic from January 1, 1999 to 
December 31, 2002 was evaluated prospectively, for aerobic Gram-positive and Gram-negative 
bacteria, and serologically for Chlamydophila pneumoniae and Mycoplasma pneumoniae. Sen-
sitivity patterns in potentially pathogenic microorganisms (PPMs) were also investigated.
Results: An infectious agent was identiﬁ  ed in 46 patients, either serologically or with sputum 
culture. Pathogens most commonly demonstrated were: Haemophilus inﬂ  uenzae (30%), Chla-
mydophila pneumoniae (17%), and Mycoplasma pneumoniae (9%). Mixed infections were 
diagnosed in 9 patients. PPMs showed a high resistance rate to commonly used antibiotics.
Conclusion: We have shown that microorganisms causing acute exacerbations of COPD are 
not only typical bacteria (46%) but also atypical pathogens (26%), with unpredictable high rates. 
Typical agents showed a high resistance to commonly used antibiotics.
Keywords: chronic obstructive pulmonary disease, acute exacerbation, infection, atypical 
pathogens, Haemophilus inﬂ  uenzae
Introduction
Chronic obstructive pulmonary disease (COPD) is one of the most prevalent disease 
in the world. Furthermore, the number of individuals affected has grown since the 
1980s and this increase is expected to continue during the next 20 years (GOLD 2001). 
COPD is characterized by intermittent acute exacerbations associated with worsening 
symptoms and lung function. These acute exacerbations contribute considerably to 
mortality and diminished quality of life (Seemungal et al 1998).
Several etiologic factors alone or in combination may cause exacerbations of 
COPD. In 50%–70% of acute exacerbations of COPD, the pathophysiological basis is 
usually infectious (Ball 1995). Haemophilus inﬂ  uenzae is the most frequent bacterium 
isolated in all series followed by Streptococcus pneumoniae, and Moraxella catarrhalis, 
and Pseudomonas aeruginosa (Ball 1995; Monso et al 1995; Soler et al 1998; 
Miravitlles et al 1999). Some reports on the role of Chlamydophila pneumoniae and 
Mycoplasma pneumoniae in acute exacerbations of COPD have appeared in recent 
years (Mogulkoc et al 1999; Lieberman et al 2001), showing that they are important 
causes of community-acquired pneumonia. However, these bacteria are usually 
almost totally absent from discussion on acute exacerbations of COPD. In the light 
of this knowledge, we prospectively designed a study to disclose the role of bacteria 
including Ch. pneumoniae and M. pneumoniae and sensitivity patterns of PPMs in 
acute exacerbations of COPD.International Journal of COPD 2008:3(3) 464
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Material and methods
Patient selection
All patients hospitalized with acute exacerbation of COPD in 
our clinic between January 1, 1999 and December 31, 2002 
were prospectively evaluated. All patients were diagnosed as 
having COPD, according to the criteria of the American Tho-
racic Society (ATS 1995). Acute exacerbation was deﬁ  ned as 
the presence of an increase in at least two of the three follow-
ing symptoms: dyspnea, cough and sputum production.
Admission to hospital was according to the clinical 
situation of the patient, or the presence of complicating factors 
such as respiratory failure by a senior chest physician, experi-
enced in the management of COPD. Exclusion criteria were: 
(1) outpatient status; (2) treatment with any antibiotic within 
48 h before admission; (3) absence of an adequate sputum 
specimen as determined by Gram stain; (4) evidence of bronchi-
ectasis and/or pneumonia; (5) malignancy or severe immuno-
supression; and (6) the need for mechanical ventilation. After a 
thorough history and physical examination, chest radiography 
and pulmonary function tests were performed. Heamatologic, 
microbiologic, and serologic investigations were done on the 
same day. Serologic investigation for Ch. pneumoniae and 
M. pneumoniae was repeated 21 days later.
Laboratory investigations
Sputum cultures
At least one sample of spontaneously expectorated sputum 
for microbiological evaluation was obtained from all patients 
during admission. A Gram’s stain of sputum in the area of 
maximal purulence was examined for polymorphonuclear 
leukocytes and epitelial cells. The criteria used to determine 
whether a sputum sample was acceptable for analysis were: 
a microbiological study using a low-magniﬁ  cation ﬁ  eld 
(× 100) revealed  10 epithelial cells and  25 leukocytes 
(Murray et al 1975). Sputum specimens not fullﬁ  lling these 
criteria were not cultured because they were not considered 
representative bronchial samples.
Sputum samples were plated on blood, eosin-methylene 
blue and chocolate agar and incubated at 37 °C for both 24 h 
and 48 h. All microorganisms isolated were identiﬁ  ed through 
standard laboratory methods (Isenberg et al 1991).
Bacterial agents were classiﬁ  ed into PPM or non-PPMs, 
as described by Cabello and colleagues (1997). PPMs were 
regarded as signiﬁ  cant only if they achieved  106 cfu, except 
for S. pneumoniae where 105 cfu was deemed sufficent. 
A PPM had to grow in signiﬁ  cant concentrations irrespec-
tive of presence of non-PPMs to be considered a potential 
causative agent of an exacerbation.
Serology
All sera were investigated for the presence of immunoglobulin 
G (IgG) and immunoglobulin M (IgM) antibodies to Chla-
mydophila species, using indirect-microimmunoﬂ  uorescence 
test (Vircell SL, Microgen Bioproducts Inc., Camberley, UK). 
Serum antibodies against Ch. pneumoniae elementary bod-
ies were detected with ﬂ  uorescein-conjugated monoclonal 
goat antihuman Ig-subclass antibodies. An isolated IgM 
titer of  1:16, or IgG titer of  1:512, or a fourfold increase 
in titer of IgG or IgM, was considered evidence of acute 
Ch. pneumoniae infection. Past Ch. pneumoniae infection 
(chronic or preexisting antibody) was deﬁ  ned as an IgG titer 
of 1:64 to 1:256.
The presence of circulating IgG and IgM antibod-
ies to M. pneumoniae was detected with an indirect-
microimmunoﬂ  uorescence test (Zeus Scientiﬁ  c, Inc., NJ, 
USA). A 4-fold change in titer of IgG or IgM, or an isolated 
IgG titer of  1:128 or IgM titer of  1:16, was considered 
to evidence of acute infection.
Statistical analysis
Statistical analysis was performed with a statistical software 
system (SPSS, version 10.0; SPSS Inc., Chicago, IL, USA). 
Student’s t-test and chi-square tests were used (p value 
of  0.05 was considered statistically signiﬁ  cant).
Results
The study included 75 patients who had been diagnosed 
with acute exacerbation of COPD from a total of 156. 
The exclusion criteria were outpatient status (27 patients), 
prior antibiotic usage (21 patients), inappropriate sputum 
(15 patients), did not attend the control visit on day 21 
(7 patients), inability to perform spirometric tests (7 patients) 
and pneumonia (4 patients). Table 1 summarizes the patients’ 
clinical characteristics.
PPMs recognized as agents causing respiratory infec-
tions, whether or not they belong to the oropharyngeal or 
gastrointestinal ﬂ  ora, were identiﬁ  ed in 34 (% 45) of 75 
patients (Table 2).
Tables 3 and 4 show serological results for Ch. 
pneumoniae and M. pneumoniae.
There were mixed infections in 9 patients. In this mixed 
infection group, the most frequent micro-organisms were 
Ch. pneumoniae and H. inﬂ  uenzae (5 patients).
There was no statistical signiﬁ  cance in terms of forced 
expiratory volume in one second (FEV1) (p = 1), duration 
of hospital stay (p = 0.258), and requirement of noninvasive 
mechanical ventilation (p = 0.0689) between groups in which International Journal of COPD 2008:3(3) 465
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an etiological agent responsible for acute exacerbation was 
identiﬁ  ed or not. Bacteriological and serological results did 
not differ among patients using noninvasive mechanical 
ventilation (NIMV). According to the sensitivity results of 
PPMs cultivated from the patients, H. inﬂ  uenzae was resistant 
to penicilin in 10 patients, and to ampicillin in 9 patients 
(Table 5). In 4 patients S. pneumoniae was sensitive to almost 
all of the commonly used antibiotics.
Discussion
Although there is no widely accepted deﬁ  nition of acute 
exacerbation of COPD, either in clinical practice or research, 
a recent a consensus statement deﬁ  ned exacerbations as “a 
sustained worsening of the patient’s condition, from the 
stable state and beyond normal day to day variations that is 
acute in onset and necessitates a change in regular medica-
tion in a patient with underlying COPD” (Rodriguez-Roisen 
2000). Patients who suffer the most exacerbations have 
signiﬁ  cantly lower health status (Seemungal et al 1998) 
and there is also some evidence that exacerbation frequency 
predicts an accelerated decline in lung function (Kanner 
et al 2001).
Table 1 Characteristics of the patients*
No of subjects 75
Male/female 71/4
Age 61.1 (41–77)
Smoking
 Smokers 12  (16%)
 Exsmokers 59  (78.6%)
 Nonsmokers 4  (5.35%)
 Pack-years 43.6  (6–100)
Number of exacerbations last year 2.3 (0–6)
Leukocytes (×109/L) 10.127
Lung function
 FEV1, L 0.774 (0.4–1.63)
 FEV1, % pred 30.8 (13–59)
  FVC, L 1.680 (0.51–2.4)
  FVC, % pred 42.5 (20–86)
 FEV1/FVC 50.2 (35–71)
Arterial blood gases
 PaO2 (mmHg) 58.9 (37–75)
 PaCO2 (mmHg) 43.2 (12–72)
 SatO2 (%) 81.1 (70–97)
Patients using oxygen therapy 70
Patients using NIMV 40
Note: *Values are given mean (%) and mean (range).
Abbreviations: FEV1, forced expiratory volume in one second; FVC, forced vital 
capacity; NIMV, noninvasive mechanical ventilation.
Table 2 Microorganisms isolated from sputum cultures and 
serologic results for 75 patients
PPMs  
Haemophilus inﬂ  uenzae1 23
Streptococcus pneumoniae 4
Haemophilus parainﬂ  uenzae 3
Enterobacter aeruoginosa 1
Serratia marcescens 1
Klebsiella oxytoca 1
Klebsiella pneumoniae 1
Acinetobacter 1
Total PPM 35
Non-PPMs 40
Other
 Chlamydophila  pneumoniae2 13
 Mycoplasma  pneumoniae 7
Notes: 1Includes one mixed infection with S. Pneumoniae;  2Includes eight mixed infections; 
ﬁ  ve with H. inﬂ  uenzae, two with M. pneumoniae and one with K. Pneumoniae.
Abbreviation: PPMs, potentially pathogenic microorganisms.
Infections play a major role in the etiology of acute 
exacerbations (Ball 1995). Patients with COPD have sig-
niﬁ  cant impairment of their lung defence mechanisms and 
colonisation of bronchial system seems to be an important 
consequence of the disease, both in stable state and in exacer-
bations. For more than 50 years, researchers have been trying 
to explain the meaning of bacteria recovered from a sputum 
culture in a COPD patient really means. Does the isolation 
of these bacteria along with mucus hypersecretion contribute 
to the pathogenesis of the disease? Is it simply a bacterial 
colonisation, or should it be treated? Distinguishing between 
colonisation and infection is difﬁ  cult in these patients. In most 
of the reported series, the predominant organisms responsible 
for infective exacerbations are S. pneumoniae, nontypical 
H. inﬂ  uenzae, and to some extent Moraxella catarrhalis 
(Ball 1995; Monso et al 1995; Soler et al 1998; Miravitlles 
et al 1999). Our study results, in which the predominant 
bacteria isolated were H. inﬂ  uenzae, correlate with most of 
the previous ones in terms of bacterial etiology.
We have also investigated the role of Ch. pneumoniae 
and M. pneumoniae in acute exacerbations of COPD. We 
have seen an atypical etiology in 20 of 46 patients in whom 
an infectious etiology was determined from a total of 75 
patients. This high percentage (26%) implicates the role 
of atypical agents in the acute exacerbations of COPD. In 
13 patients (17%), the sole agent was Ch. pneumoniae or 
M. pneumoniae and there were mixed infections in 7 patients 
(9%) with other bacteria. Data in the literature is uncertain 
on the role of atypical pathogens in the etiology of acute International Journal of COPD 2008:3(3) 466
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Table 3 Serologic results of Chlamydophila pneumoniae
Serology Patient (number)
IgM titer   1:16 1
IgG titer   1:512 1
A fourfold rise in IgG titer 11
Table 4 Serologic results of Mycoplasma pneumoniae
Serology Patient (number)
IgM   1:16 1
IgG   1:128 3
A fourfold rise in IgG titer 3
exacerbations of COPD. Two studies of acute exacerbations 
(one in hospitalised patients and one in outpatients) found 
Ch. pneumoniae in approximately 5% (Beaty et al 1991; 
Verkooyen et al 1997). Two other recent studies have found 
Ch. pneumoniae to be associated with 24% and 34% of 
exacerbations (Mogulkoc et al 1999; Karnak et al 2001). 
Because M. pneumoniae infects mainly young adults, and 
immunity may have been gained by the time acute exacerba-
tion of COPD occurs, this agent may have a less important 
role in the etiology of advanced-age COPD patients. It is not 
surprising to see in most studies, as in ours, less evidence 
of exacerbations with M. pneumoniae than Ch. pneumoniae 
(Mogulkoc et al 1999; Lieberman et al 2001). We found 
only one study related to the role of Legionella species in 
acute exacerbation of COPD (Lieberman et al 2002). This 
study demonstrated serological evidence of infection with 
Legionella species in 16.7% of patients. We would have pre-
ferred to include this species in our study in addition to viral 
etiologies. But, technical and economic problems prevented 
us from studying these agents.
Functional impairment is a predictor of the bacteria 
responsible for acute infective exacerbations in COPD 
patients. In one study, more than 56% of patients with a 
FEV1   50% had Gram-negative-bacilli as etiology of acute 
exacerbation (Miravitlles et al 1999). Our study population 
had a mean FEV1 of 30%, an even worse functional impair-
ment, well correlated with this study with a high gram-
negative predominance (88%).
In this analysis of the sensitivity of micro-organisms 
to different antibiotics, we noted especially the poor efﬁ  -
cacy of penicillin, ampicillin, amoxicillin-clavulanic acid, 
tetracyclin and erythromycin to most prevelant respiratory 
pathogens. Ciproﬂ  oxacin seems to be the most efﬁ  cient drug 
for all microorganisms. The sensitivity results show severe 
functional impairment with Gram-negative predominance 
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and also prior antibiotic usage during the lengthy course of 
COPD. These results were consistent with some studies in 
recent years (Miravitlles et al 1999), which showed similar 
sensitivity patterns in COPD patients.
In conclusion, atypical pathogens as well as typical bac-
teria may have a role in acute exacerbations of COPD. High 
resistance to commonly used antibiotics for typical agents and 
mixed infections in these severe functionally impaired cases 
of COPD were remarkable. We recommend that these results 
be considered when choosing an antibiotic in severe cases of 
COPD, although further studies are needed for clariﬁ  cation.
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